Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Prim Care Community Health ; 12: 21501327211014088, 2021.
Article in English | MEDLINE | ID: mdl-33971764

ABSTRACT

BACKGROUND: Dementia is one of the world's greatest public health issues. Most people with dementia receive home care, and family members are vulnerable to feeling burdened and depressed that reinforces the need for caregiver-driven services to mitigate these negative effects. OBJECTIVE: The purpose of this research was to evaluate the effect of the psychoeducational program on burden and quality of life of family caregivers for people with dementia. METHODS: This randomized controlled trial (RCT) was conducted on 60 family caregivers. Participants were randomly assigned to receive either the 8-session psychoeducational program (study group) or routine care only (control group). The demographic data of the caregivers and their patients, the burden of caregivers using Zarit Burden Interview (ZBI), and the quality of life of the patients using Quality of Life in Alzheimer Disease (QoL-AD) questionnaire were measured before and after the psychoeducational program and compared between the study group and the control group. RESULTS: The results revealed that 80% of the family caregivers were female and 42% were daughters. The mean ± SD of the baseline burden was 61 ± 13.7 and 60.9 ± 10 in the study and the control group, respectively. ZBI burden score in the study group demonstrated a significant drop after the psychoeducational program compared to the control group. Logistic regression analysis showed that caregivers who received the psychoeducational program have OR (95% CI) of 14 (3.1-67.8) compared to those who did not receive the psychoeducational program. CONCLUSIONS: Psychoeducational program is effective in reducing the family caregivers' perceived burden. These findings need to be considered in developing comprehensive dementia care programs to well increase the strategies that help caregivers to deal with their patients.


Subject(s)
Caregivers , Dementia , Family , Female , Humans , Quality of Life , Surveys and Questionnaires
2.
Luminescence ; 32(8): 1541-1546, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28660707

ABSTRACT

A fluorescent probe was developed and characterized, it consisted of terbium(III) with 3-ally-salicylohydrazide in ethanol, in which the 1:2 [Tb3+ :S1 ] molar ratio was the best stoichiometric ratio for the probe. The ligand 3-ally-salicylohydrazide (S1 ) was synthesized, then was confirmed by IR, CHN, LC-MS and 1 H NMR. The sensitivity of the probe's fluorescence spectra towards the presence of eight organophosphorus pesticides in ethanolic solution was studied, in which the probe showed marked sensitivity towards dichlorvos pesticide. A tangible enhancement of the probe's fluorescence intensity was observed as a consequence of the gradual addition of dichlorvos pesticide. The calculated limit of detection (LOD) was 1.183 µM and limit of quantitation (LOQ) was 3.94 µM. Further characterization of the nature of forces acting in the interaction of the probe with dichlorvos was performed by calculation of binding constants at different temperatures according to the Benesi - Hildebrand equation, and the thermodynamic parameters ΔH, ΔS and ΔG. In order to assess the analytical applicability of the method, the influence of various potentially interfering anion and cations that naturally occur in water and soil were calculated.


Subject(s)
Dichlorvos/analysis , Fluorescent Dyes/chemistry , Hydrazines/chemistry , Organometallic Compounds/chemistry , Salicylates/chemistry , Terbium/chemistry , Fluorescence , Fluorescent Dyes/chemical synthesis , Organometallic Compounds/chemical synthesis
3.
Rom J Intern Med ; 54(3): 184-189, 2016 Sep 01.
Article in English | MEDLINE | ID: mdl-27658167

ABSTRACT

BACKGROUND: Persistent hyperparathyroidism (HPT) with hypercalcemia is prevalent after transplant and is considered a risk factor for progressive bone loss and fractures and vascular calcification, as well as the development of tubulointerstitial calcifications of renal allografts and graft dysfunction. The subtotal parathyroidectomy is the standard treatment, although currently it has been replaced by the calcimimetic cinacalcet. AIM: The hypothesis of this study is that subtotal parathyroidectomy is superior to cinacalcet for treatment of persistent secondary parathyroidectomy post renal transplant, with minimal morbidity and significantly it reduces the cost of treatment after transplantation. METHODS: We report our long-term clinical experience with either cinacalcet or parathyroidectomy in 59 kidney transplant recipients with hyperparathyroidism. Group one included medical treatment with cinacalcet and had 45 patients while parathyroidectomy patients (group 2) were 16 patients with two of them excluded because of surgical failure. RESULTS: No difference was found between groups for any parameter. A greater short-term change of calcium and phosphorus homeostasis obtained by surgery than by cinacalcet, and in long term change, no significant difference between the two groups. CONCLUSIONS: The main findings of this study are that correction of severe hyperparathyroidism was similar in both surgical and cinacalcet groups with the absence of a difference of long-term serum iPTH 1-84 levels between the two groups.


Subject(s)
Calcimimetic Agents/therapeutic use , Cinacalcet/therapeutic use , Hyperparathyroidism, Secondary/drug therapy , Hyperparathyroidism, Secondary/surgery , Kidney Transplantation/adverse effects , Parathyroidectomy , Adolescent , Adult , Female , Humans , Hyperparathyroidism, Secondary/etiology , Male , Middle Aged , Postoperative Complications/therapy , Young Adult
4.
Immunol Lett ; 172: 84-8, 2016 04.
Article in English | MEDLINE | ID: mdl-26891954

ABSTRACT

Fas/Fas ligand (FasL) system is the most critical apoptotic signaling entity in the extrinsic apoptotic pathway; hence mutations affecting this pathway may prevent the immune system from the removal of newly-formed tumor cells, and thus lead to tumor formation. The present study investigated the association between the FasL -844T/C polymorphism and the risk of hepatocellular carcinoma (HCC) in a cohort of Egyptian patients and explored the relationship of various clinical and pathological parameters with this single nucleotide polymorphism (SNP). Blood samples were withdrawn from hundred HCC patients and 100 age-, sex- and ethnically matched controls. The FasL -844T/C (rs763110) gene polymorphism was typed from genomic DNA using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay. Genotype distributions and allelic frequencies between patients and control subjects showed that the TT homozygous patients were two times more likely to develop HCC (p=0.011). Also, the T allele was found to be a significant risk factor for the disease (OR 1.970, 95% CI 1.250-3.105, p=0.003). No association was detected between different parameters of the disease and the SNP. For the first time, our results suggest that the -844T/C polymorphism in the FasL gene confers risk to HCC. The alarming increase in the incidence of HCC in Egypt encourages further studies to document our results in a larger sample, and recommends more genetic studies hoping to define a genomic risk prediction specific to this cancer in our population.


Subject(s)
Carcinoma, Hepatocellular/genetics , Fas Ligand Protein/genetics , Liver Neoplasms/genetics , Aged , Egypt , Fas Ligand Protein/metabolism , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Risk
5.
Clin Rheumatol ; 33(6): 791-7, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24623460

ABSTRACT

This study aimed to determine the frequency of rheumatoid factor (RF) and cyclic citrullinated peptide (CCP) antibodies in a cohort of patients with palindromic rheumatism (PR) and to find determinants for progression to rheumatoid arthritis (RA). All new cases of PR (n=90) were included prospectively and followed up for 1 year, and a comparison group of RA cases (n=70) was also included. At study entry in all patients in both groups, RF and anti-CCP antibodies were tested, and the findings were compared and correlated. In the PR group at presentation, RF was positive in 30 patients (33.3%) and, in the RA group, in 45 patients (64.3%). Anti-CCP antibodies were positive in 35 patients (38.9%) with PR and in 58 patients (82.9%) with RA. In the PR group, positive correlations were observed between RF and C-reactive protein (CRP) (p=0.036), while anti-CCP positively correlated with disease duration (p=0.015) and CRP (p<0.001). At 1-year follow-up, 25 cases (27.5%) had progressed to RA, 3 (3.3%) cases had developed systemic lupus, 43 cases had responded to hydroxychloroquine with complete remission, five cases had developed other rheumatic diseases, and 14 cases had progressed to undifferentiated arthritis. After regression analysis, the involvement of hand joints and positive anti-CCP were the only predictors that determined progression into RA within a year (p<0.001 and p=0.02, respectively). Early hand joint involvement and positive anti-CCP at disease onset are good predictors for progression to RA in this domain.


Subject(s)
Antibodies/blood , Arthritis, Rheumatoid/blood , Hand Joints/pathology , Peptides, Cyclic/blood , Adult , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/immunology , C-Reactive Protein/metabolism , Disease Progression , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Regression Analysis , Remission Induction , Rheumatoid Factor/blood
6.
Ann Saudi Med ; 33(1): 57-62, 2013.
Article in English | MEDLINE | ID: mdl-23458943

ABSTRACT

BACKGROUND AND OBJECTIVES: The clinical use of cisplatin (CP) is highly limited because of its renal toxicity and the production of reactive oxygen species (ROS) that intensify the cytotoxic effects. Oxytocin (OT) was previously shown to have antioxidant activity. DESIGN AND SETTING: Experimental study on male Wistar albino rats performed in the Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. METHODS: Forty-eight male Wistar albino rats were classified into four equal groups: a control group, OT only-treated group which received OT twice (500 micro g/kg intraperitoneally (ip) 30 minutes and just before saline administration), a CP-induced nephrotoxicity group that received a single dose of CP (7.5 mg/kg ip) and treated with saline, and CP+OT group treated with the same previous doses. Seventy-two hours after CP administration, the rats were sacrificed and blood was withdrawn for determination of urea, creatinine, albumin and lactate dehydrogenase (LDH). The kidneys were extracted for histopathological examination and determination of the tissue levels of reduced glutathione (GSH), thiobarbituric acid reactive substances (TBARS) and nitric oxide end product nitrite (NO(2)). Glutathione S-transferase (GST), catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx) and myeloperoxidase (MPO) activities were assessed. RESULTS: CP-induced renal injury was evidenced histopathologically and manifested by a significant increase in serum LDH activity as well as urea and creatinine levels. Moreover, renal injury was associated with decreased renal tissue activities of CAT, SOD, GPx and GST as well as GSH level. On the other hand, renal tissue content of TBARS and NO(2) as well as the activity of MPO were increased. Alterations in these biochemical and histopathological indices due to CP were attenuated by OT. CONCLUSION: OT protected rats from CP-induced nephrotoxicity. Such protection is attributed, at least in part, to its antioxidant activity.


Subject(s)
Antioxidants/pharmacology , Cisplatin/toxicity , Kidney/drug effects , Oxidative Stress/drug effects , Oxytocin/pharmacology , Analysis of Variance , Animals , Antioxidants/metabolism , Antioxidants/therapeutic use , Cisplatin/metabolism , Glutathione/metabolism , Kidney/enzymology , Kidney/pathology , Lactate Dehydrogenases/blood , Lactate Dehydrogenases/metabolism , Male , Nitric Oxide/metabolism , Oxytocin/metabolism , Oxytocin/therapeutic use , Rats , Rats, Wistar , Thiobarbituric Acid Reactive Substances/metabolism
7.
Cancer Genet ; 205(12): 636-43, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23182962

ABSTRACT

Using fluorescence in situ hybridization (FISH) analysis, we examined the replication mode of the centromere region (homologous counterpart) and the aneuploidy level of chromosome 17 in the interphase nuclei of phytohaemagglutinin (PHA)-stimulated peripheral blood lymphocytes from (1) patients with hepatocellular carcinoma (HCC); (2) patients with liver cirrhosis (LC) due to hepatitis C viral infection who are individuals at a higher increased risk for HCC; and (3) healthy control participants. We also compared the allelic-replication asynchrony and aneuploidy frequencies with serum alpha-fetoprotein (AFP) levels. We found a significant increase in centromeric replication asynchrony accompanied by a high frequency of aneuploidy in lymphocytes of HCC patients compared with those of LC patients and healthy control participants. These changes are similar to those previously observed in other types of malignancy (hematological, ovarian, prostate, and breast cancer). The cytogenetic alterations of aneuploidy and strong asynchronous replication displayed in the lymphocytes of HCC patients arose from malignancy, as they were associated neither with an increased risk for cancer nor with an infection. The cytogenetic cancer-associated markers observed in patients' lymphocytes appeared to be superior to serum AFP, the marker currently used for HCC. Thus, the cytogenetic cancer-associated markers may be potentially useful in noninvasive cancer detection.


Subject(s)
Aneuploidy , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , DNA Replication/genetics , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Lymphocytes/pathology , Base Sequence , Carcinoma, Hepatocellular/blood , Case-Control Studies , Cell Nucleus/genetics , Centromere/genetics , Chromosomes, Human, Pair 17/genetics , Humans , In Situ Hybridization, Fluorescence , Interphase/genetics , Liver Neoplasms/blood , Middle Aged , ROC Curve , Sensitivity and Specificity , alpha-Fetoproteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...